comprehensive -WSS

comprehensive

author：focus 2025-09-01 23:44:41 - browse：917

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： TikTok cracks down on users posting about weight loss drugs

Wikipedia

WSS

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

'Make People Better': The CRISPR babies story you probably don't know

How to fix cancer clinical trials' diversity problem

What American doctors can learn from their Israeli counterparts

Ethical issues complicate the benefits of medical crowdfunding

hotspot

comprehensive

knowledge

Moonlake's readout produced a cash windfall. Risks remain

Advances in CAR

What does generative AI mean for health care? We asked experts

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

The cancer drug shortage isn’t new — and neither are the solutions

Seattle police shoot person suspected in downtown stabbing

Guidelines to prevent youth baseball injuries need more muscle

The (many) problems with a new study criticizing cancer screening

George Santos makes 1st court appearance after pleading not guilty to 13 counts

NIH nominee Bertagnolli will get October confirmation hearing

entertainment

Humana sues Biden admin over Medicare Advantage audit rule

Illumina names Agilent executive as new CEO

The 10 drugs up first for Medicare price negotiation

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

The (many) problems with a new study criticizing cancer screening

Crinetics acromegaly drug succeeds in late

Wikipedia

Wikipedia

hotspot

knowledge